Some women with breast cancer are calling it quits with their aromatase inhibitor

Some women with breast cancer are calling it quits with their aromatase inhibitor...Arimidex, Aromasin, and Femara.

Aromatase inhibitors work better than tamoxifen to prevent recurrence of estrogen-receptor positive breast cancer in postmenopausal women.

And they were initially thought to be better tolerated.